Polskie Radio runs a story framing drugs like Ozempic as the cause of a health crisis. Only the headline came through, so read the source for its reasoning.
Recap by typeshit. Full story at www.polskieradio.pl.
Reuters reports the trend among GLP-1 users is prompting calls for tighter rules on supplements sold alongside the drugs.
A pharmacist account flags two separate Class II recalls involving compounded tirzepatide. Tap through for which products are affected and why.
Health authorities in New South Wales issued a warning after a jump in hospitalisations linked to unapproved peptides sold as wellness products.
A University of Iowa chemist found no peptide in a Brooklyn corner-store vial, and another expert flagged at least 13 bacterial colonies that could cause infection.
Oral Wegovy brought in about $850 million in H1 2026 and holds over 80% of new US oral scripts. Lilly says Foundayo volume doubled in a month.
The Long Covid account is hosting a live discussion at 6pm UK on whether GLP-1 drugs might help with Long Covid symptoms.
Loading…